West Pharmaceutical Services (WST) Asset Utilization Ratio (2010 - 2026)

West Pharmaceutical Services (WST) has reported Asset Utilization Ratio for 17 consecutive years, with 0.81 the latest figure, recorded in Q2 2026.

• Quarterly Asset Utilization Ratio rose 3.94% year-over-year to 0.81 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.81 (up 3.94% YoY) and the FY2025 annual result came in at 0.78, changed 0.34% from the prior year.
• Asset Utilization Ratio advanced to 0.81 in Q2 2026 per WST's latest filing, from 0.77 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for WST reached as high as 0.88 in Q2 2022 and fell as low as 0.73 in Q4 2025.
• A 5-year average of 0.8 and a median of 0.79 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio declined 11.89% — and 2024, when it grew 4.65%.
• Year by year, Asset Utilization Ratio stood at 0.83 in 2022, then fell by 6.59% to 0.78 in 2023, then increased by 1.64% to 0.79 in 2024, then retreated by 7.16% to 0.73 in 2025, then rose by 10.73% to 0.81 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.81, 0.77, and 0.73 for Q2 2026, Q1 2026, and Q4 2025 respectively.